查询词典 breast-high

However, Dr Sarah Rawlings, of the charity Breakthrough Breast Cancer, said:"This is very early research that has only been carried out in mice so we don't actually know if it could be used in women."

然而，慈善机构Breakthrough Breast Cancer的Sarah Rawling博士说，"这是一个非常初期的研究，仅在老鼠身上做过试验，因此我们并不知道它是否可以用于人类。"

Methods By immunohistochemical method, the expression of bcl-2 and bad gene were observed in 8 cases of normal breast tissues 19 cases of breast hyerplasia, 20 cases of breast atypical, 48 cases of breast cancer in situs ,and test the expression of ER , PR and bcl-2 , bad in the breast cancer, Eight normal breast tissues were used control.

利用免疫组织化学染色SABC法，原位观察19例乳腺单纯性增生，20例乳腺非典型增生，48例乳腺癌组织中bcl-2、bad蛋白的表达以8例正常乳腺组织作对照。

As the rapid development of contemporary biochemistry technology, new-style beautiful breast cosmetic is increasing also, apparent to beautiful breast effect biochemistry additive appears ceaselessly, if placenta extracts albumen of content, royal jelly, collagen, serum to wait, curative effect of product of these biology beautiful breast is apparent and safety does not have side-effect; Product of the natural plant that is a delegate with Chinese herbal medicine beautiful breast its characteristic is safety, effect good, cost is low; Have already in product of a few series can make make the same score pectoral ridgy abundant breast element, have again in the light of Female The bounce elite element with flabby, flagging breast, still have gel of be good at bosom, agent of sparge of be good at bosom.

随着现代生化技术的迅速发展，新型的美乳化妆品也越来越多，对美乳效果明显的生化添加剂不断出现，如胎盘提取物、蜂王浆、胶原蛋白、血清等，这些生物型美乳产品疗效明显且安全无副作用；以中草药为代表的天然植物型美乳产品其特点是安全、效果好、成本低；一些系列产品中既有可使平胸隆起的丰乳素，又有针对女性乳房松弛、下垂的弹力精华素，还有健胸凝胶，健胸喷雾剂等。

Itshows that the dimension reduction algorithm based on the tangent bundle is an effectivemethod by dimensionality reduction experiments on handwritten data and breast cancer data.

通过对手写体数据的降维实验和Breast Cancer实验表明，基于切丛的维数约简方法是一种有效的降维算法。

Breast shells and nipple preparation are often recommended to help evert flat or inverted nipples.

Breast shells和乳头的准备工作常常会被推荐给有着平或者是内陷乳头的ZMM或者妈妈。

Methods Measurements were made in a group of 45 women volunteers aged from 22 to 45 years, who were satisfied with their breasts without any history of breast surgery. After the lateral arch of the breast as the reference value for breast size being chosen, breast-areola to nipple ratio was determined according to parameters measured as follows: weight, height, diameter of the breast, areola, and nipple, distances between the nipple and borders of the breast-superior, medial arch (to the medial end of the inframammary crease), lateral arch (to the lateral end of the inframammary crease), inferior arch (to the lowest point of the inframammary crease).

方法对45例22~45岁、对自己乳房满意且无乳房手术史的女性志愿者，分别测量体重、身高、乳头直径、乳晕直径、胸乳线(乳头至胸骨切迹连线距离)、乳房内侧半径(乳头至乳房下皱襞内侧止点连线距离)、乳房外侧半径(乳头至乳房下皱襞外侧止点连线距离)、乳房下半径(乳头至乳房下皱襞最低点连线距离)。

Breast-conserving therapy, consisting of lumpectomy and radiation, has been demonstrated in the past to be a safe, effective treatment for nonhereditary or sporadic forms of early breast cancer.

保留乳房的乳腺癌切除术(Breast-conserving therapy， BCT)，包括乳房局部病灶切除术和放疗，用于治疗非遗传性或者散发性早期乳腺癌已经被证明是安全有效的。

OBJECTIVE The hereditary breast and orarian cancer susceptibility gene(BRCA1) is known as a kind of anti-oncogene.

目的 遗传性乳腺癌和卵巢癌易感基因(hereditary breast and orarian cancer susceptibility gene， BRCA1)是一种抑癌基因。

Objective: To study the role of the hereditary breast and orarian cancer susceptibiliry gene mutation and estrogen receptor in breast cancer and study the relationship between BRCA1 and ER.

目的 探讨与遗传性乳腺癌与卵巢癌相关的易感基因(Hereditary breast and orarian cancer susceptibility gene， BRCA1)基因突变、雌激素受体(Estrogen receptor， ER)在乳腺癌中的作用以及二者之间的关系。

objective:to analyze the difference between mammary duct ectasiaand plasma cell mammitis.methods:the data of 24 cases of mde and 28 cases of pcm,including clinical manifestations,distinguished diagnoses,surgical therapy,pathological results,were analyzed.results:the clinical manifestations of mde are nipple discharge and breast mass,which should be distinguished with breast mass and early stage of breast cancer.the treatment is local resection.major pathological changes are duct ectasia and obvious periductal inflammatory changes.the clinical manifestations of pcm are breast mass and inflammatory changes,which should to be distinguished with advanced breast cancer and inflammatory breast cancer.the surgical treatment is extensive resection.the major pathological changes are inflammatory reaction and multiple abscesses in breast tissue.conclusion:mde and pcm are significant different,and they are different progressing stage of disease,thus the two diagnoses are independent.

目的：分析乳腺导管扩张症和浆细胞性乳腺炎临床上的差异。提出各自独立诊断的论据。方法：结合24例乳腺导管扩张症和28例浆细胞性乳腺炎对两病的临床症状、鉴别诊断、手术治疗、病理结果进行比较分析。结果：乳腺导管扩张症临床表现为乳头溢液和乳腺肿物，主要与乳腺肿物和早期乳腺癌鉴别诊断，手术以局部切除多见，病理表现为导管扩张及导管周围明显炎性改变。浆细胞性乳腺炎临床表现为乳腺肿物和炎性改变，主要与晚期乳腺癌和炎性乳腺癌鉴别诊断，手术切除的范围较大，病理变化以乳腺组织的炎性反应和多发性脓肿为主。结论：乳腺导管扩张症和浆细胞性乳腺炎有明显的差异，应作为这两种疾病独立诊断。

What are your goals and strategies for growth?

你的成长目标和策略是什么？

And unto the angel of the church in Sardis write; These things saith he that hath the seven irits of God, and the seven star I know thy works, that thou hast a name that thou livest, and art dead.

3：1 你要写信给撒狄教会的使者，说，那有神的七灵和七星的，说，我知道你的行为，按名你是活的，其实是死的。